FDA.reportPublic FDA data

2 ML amisulpride 2.5 MG/ML Injection

RxCUI
2284232
RxNorm name
2 ML amisulpride 2.5 MG/ML Injection
Display name
2 ML amisulpride 2.5 MG/ML Injection
Full name
2 ML amisulpride 2.5 MG/ML Injection
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:15

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
ab23bc6e-b6a8-165f-e053-2a95a90ab1442 ML amisulpride 2.5 MG/ML InjectionSCD7These highlights do not include all the information needed to use BARHEMSYS safely and effectively. See full prescribing information for BARHEMSYS. BARHEMSYS ® (amisulpride) injection, for intravenous use Initial U.S. Approval: 202020250609
ab23bc6e-b6a8-165f-e053-2a95a90ab144amisulpride 5 MG per 2 ML InjectionSY7These highlights do not include all the information needed to use BARHEMSYS safely and effectively. See full prescribing information for BARHEMSYS. BARHEMSYS ® (amisulpride) injection, for intravenous use Initial U.S. Approval: 202020250609
ab23bc6e-b6a8-165f-e053-2a95a90ab144amisulpride 2.5 MG/ML per 2 ML InjectionSY7These highlights do not include all the information needed to use BARHEMSYS safely and effectively. See full prescribing information for BARHEMSYS. BARHEMSYS ® (amisulpride) injection, for intravenous use Initial U.S. Approval: 202020250609
ab23bc6e-b6a8-165f-e053-2a95a90ab144amisulpride 5 MG in 2 mL InjectionPSN7These highlights do not include all the information needed to use BARHEMSYS safely and effectively. See full prescribing information for BARHEMSYS. BARHEMSYS ® (amisulpride) injection, for intravenous use Initial U.S. Approval: 202020250609